Literature DB >> 27455035

Delirium frequency among advanced cancer patients presenting to an emergency department: A prospective, randomized, observational study.

Ahmed F Elsayem1, Eduardo Bruera2, Alan D Valentine3, Carla L Warneke4, Sai-Ching J Yeung1, Valda D Page1, Geri L Wood5, Julio Silvestre1, Holly M Holmes6, Patricia A Brock1, Knox H Todd1.   

Abstract

BACKGROUND: The frequency of delirium among patients with cancer presenting to the emergency department (ED) is unknown. The purpose of this study was to determine delirium frequency and recognition by ED physicians among patients with advanced cancer presenting to the ED of The University of Texas MD Anderson Cancer Center.
METHODS: The study population was a random sample of English-speaking patients with advanced cancer who presented to the ED and met the study criteria. All patients were assessed with the Confusion Assessment Method (CAM) to screen for delirium and with the Memorial Delirium Assessment Scale (MDAS) to measure delirium severity (mild, ≤15; moderate, 16-22; and severe, ≥23). ED physicians were also asked whether their patients were delirious.
RESULTS: Twenty-two of the 243 enrolled patients (9%) had CAM-positive delirium, and their median MDAS score was 14 (range, 9-21 [30-point scale]). The median age of the enrolled patients was 62 years (range, 19-89 years). Patients with delirium had a poorer performance status than patients without delirium (P < .001); however, the 2 groups did not differ in other characteristics. Ten of the 99 patients who were 65 years old or older (10%) had CAM-positive delirium, whereas 12 of the 144 patients younger than 65 years (8%) did (P = .6). According to the MDAS scores, delirium was mild in 18 patients (82%) and moderate in 4 patients (18%). Physicians correctly identified delirium in 13 of the CAM-positive delirious patients (59%).
CONCLUSIONS: Delirium is relatively frequent and is underdiagnosed by physicians in patients with advanced cancer who are visiting the ED. Further research is needed to identify the optimal screening tool for delirium in ED. Cancer 2016.
© 2016 American Cancer Society. Cancer 2016;122:2918-2924. © 2016 American Cancer Society. © 2016 American Cancer Society.

Entities:  

Keywords:  Confusion Assessment Method; Memorial Delirium Assessment Scale (MDAS); delirium; emergency department; frequency; physician diagnosis

Mesh:

Year:  2016        PMID: 27455035     DOI: 10.1002/cncr.30133

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  [Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus].

Authors:  Dong-Sheng Zhang; Jia-Wei Zheng; Chen-Ping Zhang; Zhi-Gang Cai; Long-Jiang Li; Gui-Qing Liao; Zheng-Jun Shang; Mo-Yi Sun; Zheng-Xue Han; Wei Shang; Jian Meng; Zhong-Cheng Gong; Sheng-Yun Huang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-12-01

Review 2.  The Dilemma of Treating Delirium: the Conundrum of Drug Management.

Authors:  Meera R Agar; Ingrid Amgarth-Duff
Journal:  Curr Treat Options Oncol       Date:  2022-05-11

3.  Advance Directives, Hospitalization, and Survival Among Advanced Cancer Patients with Delirium Presenting to the Emergency Department: A Prospective Study.

Authors:  Ahmed F Elsayem; Eduardo Bruera; Alan Valentine; Carla L Warneke; Geri L Wood; Sai-Ching J Yeung; Valda D Page; Julio Silvestre; Patricia A Brock; Knox H Todd
Journal:  Oncologist       Date:  2017-08-01

4.  Characteristics of Younger and Older Adults with Hospital-Acquired Delirium: a Claims Data Study Spanning 14 years.

Authors:  Nidhi Rohatgi; Yingjie Weng; Neera Ahuja; Maarten G Lansberg
Journal:  J Gen Intern Med       Date:  2021-01-08       Impact factor: 5.128

5.  Factors Associated with Hospital-Acquired Delirium in Patients 18-65 Years Old.

Authors:  Nidhi Rohatgi; Yingjie Weng; Neera Ahuja; Maarten G Lansberg
Journal:  J Gen Intern Med       Date:  2021-01-08       Impact factor: 5.128

6.  Identification of patients with cancer with a high risk to develop delirium.

Authors:  Elisabeth C W Neefjes; Maurice J D L van der Vorst; Bertha A T T Verdegaal; Aartjan T F Beekman; Johannes Berkhof; Henk M W Verheul
Journal:  Cancer Med       Date:  2017-07-07       Impact factor: 4.452

7.  Pilot Study of Lemborexant for Insomnia in Cancer Patients with Delirium.

Authors:  Tatsuto Terada; Takatoshi Hirayama; Ryoichi Sadahiro; Saho Wada; Rika Nakahara; Hiromichi Matsuoka
Journal:  J Palliat Med       Date:  2022-01-28       Impact factor: 2.947

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.